JP2004503238A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503238A5
JP2004503238A5 JP2002510643A JP2002510643A JP2004503238A5 JP 2004503238 A5 JP2004503238 A5 JP 2004503238A5 JP 2002510643 A JP2002510643 A JP 2002510643A JP 2002510643 A JP2002510643 A JP 2002510643A JP 2004503238 A5 JP2004503238 A5 JP 2004503238A5
Authority
JP
Japan
Prior art keywords
gene product
cell
cancerous
differentially expressed
colon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004503238A (ja
JP5363695B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/019313 external-priority patent/WO2001096523A2/en
Publication of JP2004503238A publication Critical patent/JP2004503238A/ja
Publication of JP2004503238A5 publication Critical patent/JP2004503238A5/ja
Application granted granted Critical
Publication of JP5363695B2 publication Critical patent/JP5363695B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510643A 2000-06-15 2001-06-15 結腸癌に関するポリヌクレオチド Expired - Fee Related JP5363695B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21183500P 2000-06-15 2000-06-15
US60/211,835 2000-06-15
PCT/US2001/019313 WO2001096523A2 (en) 2000-06-15 2001-06-15 Polynucleotides related to colon cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011174312A Division JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Publications (3)

Publication Number Publication Date
JP2004503238A JP2004503238A (ja) 2004-02-05
JP2004503238A5 true JP2004503238A5 (enExample) 2008-07-10
JP5363695B2 JP5363695B2 (ja) 2013-12-11

Family

ID=22788525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002510643A Expired - Fee Related JP5363695B2 (ja) 2000-06-15 2001-06-15 結腸癌に関するポリヌクレオチド
JP2011174312A Pending JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011174312A Pending JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Country Status (9)

Country Link
US (1) US20030008284A1 (enExample)
EP (2) EP1370684B1 (enExample)
JP (2) JP5363695B2 (enExample)
AT (1) ATE397094T1 (enExample)
AU (1) AU2001269867A1 (enExample)
DE (1) DE60134275D1 (enExample)
ES (2) ES2305087T3 (enExample)
PT (1) PT1370684E (enExample)
WO (1) WO2001096523A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
WO2004018648A2 (en) * 2002-08-26 2004-03-04 Case Western Reserve University Methods for treating patients and identifying therapeutics
CA2500731A1 (en) * 2002-10-02 2004-04-15 Robert Y. L. Tsai Methods for controlling proliferation of cells
JP4712692B2 (ja) * 2004-06-02 2011-06-29 Tssバイオテック株式会社 癌の診断と治療において有用な新規ポリペプチド
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
US8435490B2 (en) * 2007-06-21 2013-05-07 The Johns Hopkins University Small peptides specifically bind to colorectal cancers
CA2736170A1 (en) 2007-09-06 2009-03-12 Case Western Reserve University Methods for diagnosing and treating cancers
SG189774A1 (en) 2008-04-10 2013-05-31 Genenews Corp Method and apparatus for determining a probability of colorectal cancer in a subject

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5206152A (en) 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
EP0454781B1 (en) 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
DE69034168T3 (de) 1989-03-21 2013-04-11 Vical, Inc. Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
EP1645635A3 (en) 1989-08-18 2010-07-07 Oxford Biomedica (UK) Limited Replication defective recombinant retroviruses expressing a palliative
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
NZ237464A (en) 1990-03-21 1995-02-24 Depotech Corp Liposomes with at least two separate chambers encapsulating two separate biologically active substances
US5252296A (en) 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
US5149655A (en) 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
RU2142467C1 (ru) 1990-07-27 1999-12-10 Чирон Диагностикс Корпорейшн Полинуклеотиды, способ их получения, гибридизационный анализ нуклеиновой кислоты
JP3337214B2 (ja) 1990-12-20 2002-10-21 アーチ・ディベロップメント・コーポレーション 電離線による遺伝子発現の調節
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
WO1993014778A1 (en) 1992-01-23 1993-08-05 Vical, Inc. Ex vivo gene transfer
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
JPH07507689A (ja) 1992-06-08 1995-08-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 特定組織のターゲティング方法及び組成物
JPH09507741A (ja) 1992-06-10 1997-08-12 アメリカ合衆国 ヒト血清による不活性化に耐性のあるベクター粒子
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
CA2592997A1 (en) 1992-12-03 1994-06-09 Genzyme Corporation Pseudo-adenovirus vectors
AU6818094A (en) 1993-04-22 1994-11-08 Depotech Corporation Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
JP3532566B2 (ja) 1993-06-24 2004-05-31 エル. グラハム,フランク 遺伝子治療のためのアデノウイルスベクター
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5500356A (en) 1993-08-10 1996-03-19 Life Technologies, Inc. Method of nucleic acid sequence selection
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
EP0694070B1 (en) 1993-09-15 2002-04-10 Chiron Corporation Recombinant alphavirus vectors
JP3875990B2 (ja) 1993-10-25 2007-01-31 カンジ,インコーポレイテッド 組換えアデノウイルスベクターおよび使用方法
NZ276305A (en) 1993-11-16 1997-10-24 Depotech Corp Controlled release vesicle compositions
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5474397A (en) 1994-05-31 1995-12-12 Ingersoll-Rand Company Drum access mechanism
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
WO1996017072A2 (en) 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors
US5783387A (en) 1995-02-06 1998-07-21 The Regents Of The University Of California Method for identifying and quantifying nucleic acid sequence aberrations
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
AU700952B2 (en) 1995-06-07 1999-01-14 Pioneer Hi-Bred International, Inc. PCR-based cDNA subtractive cloning method
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5654173A (en) 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5981279A (en) * 1995-11-09 1999-11-09 Allegheny University Of The Health Sciences Compositions and methods to regulate calmodulin gene expression, and uses thereof for influencing cell growth and differentiation
JP2001507563A (ja) 1995-11-23 2001-06-12 キャンサー リサーチ キャンペーン テクノロジー リミテッド Brca2癌感受性遺伝子の同定及び配列決定に関する材料及び方法並びにそれらの使用
AU2189397A (en) 1996-02-08 1997-08-28 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
AU2998597A (en) 1996-05-06 1997-11-26 Chiron Corporation Crossless retroviral vectors
US6251433B1 (en) 1996-08-13 2001-06-26 Chiron Corporation Polycationic polymers
US6007991A (en) * 1997-03-28 1999-12-28 The Research Foundation Of Suny Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer
US6197332B1 (en) 1997-08-13 2001-03-06 Chiron Corporation Lipid-conjugated polyamide compounds and related compositions and methods thereof
AU1726199A (en) * 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
JP2002519000A (ja) * 1998-01-28 2002-07-02 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ii
AU764441B2 (en) * 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor
DE69938190T2 (de) * 1998-10-15 2009-03-05 Novartis Vaccines and Diagnostics, Inc., Emeryville Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
PT1144609E (pt) 1999-08-27 2008-05-28 Novartis Vaccines & Diagnostic Oligonucleótidos anti-sentido quiméricos e suas formulações para transfecção de células

Similar Documents

Publication Publication Date Title
Obama et al. Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma
KR102622307B1 (ko) 후성유전적 염색체 상호작용
JP5770472B2 (ja) ヒト急性白血病におけるepha7及びerkリン酸化の調節解除を誘発するための方法及び組成物
JP2010535473A5 (enExample)
EP3303616B1 (en) Methods of prostate cancer prognosis
CN111742061B (zh) 基于pde4d7表达和术前临床变量的术前风险分层
US20080050379A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
JP2012501164A5 (enExample)
JP2010535014A5 (enExample)
JP2005537007A5 (enExample)
JP2004503238A5 (enExample)
CN105765081A (zh) 一种用于预测对采用egfr抑制剂的治疗的响应性的方法
KR101346955B1 (ko) 뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
KR20170086469A (ko) Egfr 억제제를 사용한 치료에 대한 반응을 예측하는 방법
CN105102983A (zh) Ddr2突变作为黑素瘤或基底细胞癌的可靶向的特征
US20020115057A1 (en) Process for identifying anti-cancer therapeutic agents using cancer gene sets
CN110452989B (zh) 生物标志物在胃癌检测、诊断中的应用
JP6949315B2 (ja) 肺扁平上皮癌と肺腺癌の鑑別評価方法
JP2004187620A (ja) 腎疾患の疾患マーカーおよびその利用
JP5114796B2 (ja) 食道癌の予後診断マーカー遺伝子およびその利用
US20020165180A1 (en) Process for identifying anti-cancer therapeutic agents using cancer gene sets
KR102481242B1 (ko) 암 진단에서 후생적 염색체 상호 작용의 적용
CN107937520B (zh) 与结直肠癌相关的分子标记物、抑制剂、试剂盒和药剂
US20040115625A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
JP2005525097A5 (enExample)